Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have now emerged as a mainstay of treatment for various cancer. Along with the development of ICIs, immune-related adverse effects (irAEs) have been the subject of wide attention. The cardiac irAE, a rare but potentially fatal and fulminant effect, have been repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ru, Peng, Ling, Qiu, Zhihua, Wang, Yan, Wei, Fen, Zhou, Min, Zhu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685438/
https://www.ncbi.nlm.nih.gov/pubmed/34938778
http://dx.doi.org/10.3389/fcvm.2021.727445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685438/
https://www.ncbi.nlm.nih.gov/pubmed/34938778
http://dx.doi.org/10.3389/fcvm.2021.727445

Ejemplares similares